Pagotaisidro, Edmafe P.
HRN: 21-42-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2022
CEFUROXIME 500MG (TAB)
06/04/2022
06/11/2022
ORAL
1 Tab
BID X 7 Days
UTI
Waiting Final Action